From traditional “Big Pharma” stocks that have adopted (or are adopting) a greater focus on biotech to large “pure-play” biotech companies to “emerging” biotech stocks (including some with a specific focus on COVID-19), today’s article highlights what the author sees as 14 of the best biotech stocks to consider buying for 2021. For these 14 biotech stocks, which include options for both conservative and aggressive investors, CLICK HERE.